UnitedHealth Group (NYSE:UNH) PT Lowered to $650.00 at UBS Group

UnitedHealth Group (NYSE:UNH) had its price target cut by research analysts at UBS Group from $680.00 to $650.00 in a report issued on Wednesday, Benzinga reports. The brokerage presently has a “buy” rating on the healthcare conglomerate’s stock. UBS Group’s price objective points to a potential upside of 14.84% from the company’s current price.

Several other analysts have also recently weighed in on the company. TD Cowen raised their price target on UnitedHealth Group from $546.00 to $601.00 and gave the company a “buy” rating in a report on Wednesday, July 17th. Bank of America cut their price target on shares of UnitedHealth Group from $675.00 to $650.00 and set a “buy” rating for the company in a research note on Wednesday. Morgan Stanley dropped their price objective on shares of UnitedHealth Group from $615.00 to $610.00 and set an “overweight” rating for the company in a report on Wednesday. Robert W. Baird raised their price target on UnitedHealth Group from $597.00 to $640.00 and gave the company an “outperform” rating in a research report on Wednesday, July 17th. Finally, Jefferies Financial Group raised UnitedHealth Group from a “hold” rating to a “buy” rating and raised their price objective for the company from $481.00 to $647.00 in a report on Wednesday, July 17th. Two investment analysts have rated the stock with a hold rating, eighteen have assigned a buy rating and two have given a strong buy rating to the company’s stock. According to data from MarketBeat.com, UnitedHealth Group presently has a consensus rating of “Buy” and an average price target of $615.16.

UnitedHealth Group Stock Down 0.9 %

Shares of NYSE UNH opened at $566.00 on Wednesday. The business has a 50-day simple moving average of $584.20 and a two-hundred day simple moving average of $533.07. UnitedHealth Group has a 52 week low of $436.38 and a 52 week high of $608.63. The company has a market cap of $522.66 billion, a P/E ratio of 37.53, a P/E/G ratio of 1.69 and a beta of 0.58. The company has a quick ratio of 0.88, a current ratio of 0.88 and a debt-to-equity ratio of 0.67.

UnitedHealth Group (NYSE:UNH) last posted its earnings results on Tuesday, October 15th. The healthcare conglomerate reported $7.15 earnings per share for the quarter, topping analysts’ consensus estimates of $7.00 by $0.15. The business had revenue of $100.82 billion for the quarter, compared to analyst estimates of $99.14 billion. UnitedHealth Group had a net margin of 3.66% and a return on equity of 26.55%. UnitedHealth Group’s revenue was up 9.2% on a year-over-year basis. During the same quarter in the prior year, the firm posted $6.56 EPS. Research analysts anticipate that UnitedHealth Group will post 27.68 earnings per share for the current fiscal year.

Hedge Funds Weigh In On UnitedHealth Group

Hedge funds and other institutional investors have recently made changes to their positions in the business. Kathleen S. Wright Associates Inc. purchased a new stake in shares of UnitedHealth Group in the 3rd quarter worth about $27,000. Macroview Investment Management LLC lifted its holdings in UnitedHealth Group by 671.4% in the second quarter. Macroview Investment Management LLC now owns 54 shares of the healthcare conglomerate’s stock worth $28,000 after buying an additional 47 shares during the period. Delos Wealth Advisors LLC raised its position in shares of UnitedHealth Group by 757.1% in the 1st quarter. Delos Wealth Advisors LLC now owns 60 shares of the healthcare conglomerate’s stock worth $30,000 after acquiring an additional 53 shares in the last quarter. Bbjs Financial Advisors LLC bought a new stake in shares of UnitedHealth Group during the second quarter valued at approximately $31,000. Finally, Global Wealth Strategies & Associates raised its holdings in UnitedHealth Group by 152.4% in the third quarter. Global Wealth Strategies & Associates now owns 53 shares of the healthcare conglomerate’s stock worth $31,000 after purchasing an additional 32 shares in the last quarter. Institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.